No new drug or device action; a review of where frailty sits in assisted dying law

The regulatory sweep found no new drug approval, device recall or safety communication for this desk today. That is the usual outcome here. Most of what changes geriatric practice arrives as guidance on deprescribing, capacity assessment and end-of-life care, published by societies as web documents or by national bodies as circulars — none of which reaches the drug and device registers this sweep reads.

The closest thing to a regulatory development is a review of assisted dying law and practice as it applies to frailty. Publicly available statistics and legal provisions were examined across jurisdictions where assisted dying is regulated. Only Canada and the Netherlands report frailty prevalence among people accessing it: in Canada 9.07% of assisted deaths in 2023 involved frailty as a main condition or comorbidity, and in the Netherlands 3.85% involved multiple geriatric syndromes. Of the jurisdictions reviewed, 11 were judged unlikely to permit frailty as an eligible condition, 6 where severe frailty meets or would likely meet eligibility, and 14 where the position is simply unclear.

Assisted dying is not lawful in India, so this is context rather than instruction. What travels is the underlying problem: frailty is a trajectory rather than a diagnosis, and legal and clinical frameworks built around a named terminal illness handle it badly. The same difficulty appears in Indian practice around withdrawal of life-sustaining treatment and advance directives, where a frail patient with no single terminal diagnosis is the hardest case to document and discuss. Check your own jurisdiction's current position directly; this sweep does not see it.

• Document goals of care for frail patients before a crisis; a trajectory is harder to discuss in an emergency.
• Record capacity assessments contemporaneously and in the patient's own words where possible.
• Frailty without a single terminal diagnosis is the hardest case for any legal framework — anticipate that.
• Indian law on withdrawal of life-sustaining treatment and advance directives is outside this sweep; check it directly.
• No geriatric drug or device safety action was issued today.

The statistics, in plain English

That only two jurisdictions report frailty prevalence at all is the finding, not the percentages themselves — a figure of 9.07% from Canada and 3.85% from the Netherlands are not comparable, since they count different things under different criteria. Reviews of publicly available statistics can only describe what governments choose to publish, so absence of data here means absence of reporting rather than absence of cases.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.